Table 4 Associations of two polymorphism models in the CD160 gene with GD before and after adjusting for confounders
From: Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study
Comparison models | Unadjusted estimates | Adjusted estimatesa | ||
|---|---|---|---|---|
OR (95%CI) | P values | OR (95%CI) | P values | |
rs744877 | ||||
Allele Model | 0.84 (0.71–0.98) | 0.027 | 0.84 (0.71–0.98) | 0.030 |
Dominant Model | 0.74 (0.60–0.91) | 0.005 | 0.74 (0.60–0.92) | 0.005 |
Recessive model | 0.98 (0.69–1.37) | 0.886 | 0.98 (0.70–1.39) | 0.923 |
Homozygous model | 0.83 (0.58–1.19) | 0.315 | 0.84 (0.58–1.20) | 0.339 |
Additive model | 0.72 (0.58–0.90) | 0.004 | 0.72 (0.58–0.90) | 0.004 |
rs3766526 | ||||
Allele Model | 1.16 (0.96–1.39) | 0.122 | 1.14 (0.95–1.38) | 0.160 |
Dominant Model | 1.14 (0.91–1.41) | 0.250 | 1.12 (0.90–1.40) | 0.295 |
Recessive model | 1.60 (0.92–2.79) | 0.096 | 1.54 (0.88–2.70) | 0.130 |
Homozygous model | 1.65 (0.94–2.88) | 0.081 | 1.57 (0.89–2.77) | 0.116 |
Additive model | 1.09 (0.87–1.36) | 0.462 | 1.08 (0.86–1.36) | 0.502 |